Parnax Lab Ltd.
| BSE: 506128 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE383L01019 |
| BSE 00:00 | 24 Jun | 83.75 |
1.75 (2.13%) |
OPEN
84.95 |
HIGH
86.50 |
LOW
81.20 |
| NSE 05:30 | 01 Jan | Parnax Lab Ltd |
| OPEN | 84.95 |
| PREVIOUS CLOSE | 82.00 |
| VOLUME | 8668 |
| 52-Week high | 169.90 |
| 52-Week low | 21.00 |
| P/E | 152.27 |
| Mkt Cap.(Rs cr) | 82 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Parnax Lab Ltd. (PARNAXLAB) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 824.10 | -0.07 | 966.90 | 661.80 | 197726.31 |
| Divi's Lab. | 3680.40 | 0.38 | 5425.00 | 3365.10 | 97696.22 |
| Cipla | 933.40 | 0.04 | 1083.15 | 850.00 | 75316.05 |
| Dr Reddy's Labs | 4308.75 | 0.29 | 5613.65 | 3655.00 | 71714.84 |
| Apollo Hospitals | 3835.60 | -0.39 | 5930.70 | 3144.70 | 55148.26 |
| Torrent Pharma. | 2875.50 | 0.74 | 3304.45 | 2485.00 | 48659.21 |
| Gland Pharma | 2643.70 | 1.40 | 4350.00 | 2498.00 | 43541.74 |
| Piramal Enterp. | 1651.10 | 1.37 | 3013.00 | 1561.00 | 39403.50 |
| Biocon | 326.90 | 0.08 | 414.30 | 309.30 | 39247.61 |
| Abbott India | 18088.00 | 0.34 | 23902.30 | 15525.00 | 38437.00 |
| Zydus Lifesci. | 353.70 | 2.18 | 655.00 | 319.40 | 36208.27 |
| Max Healthcare | 371.90 | 1.51 | 472.60 | 251.00 | 36060.54 |
| Alkem Lab | 3003.85 | -1.15 | 4067.70 | 2835.00 | 35911.03 |
| Aurobindo Pharma | 526.40 | 1.75 | 1012.90 | 503.40 | 30841.78 |
| Lupin | 629.95 | 0.15 | 1193.00 | 583.05 | 28634.38 |
| Glaxosmi. Pharma | 1499.75 | -0.06 | 1917.00 | 1433.05 | 25407.27 |
| Laurus Labs | 466.60 | 1.52 | 723.55 | 433.20 | 25072.75 |
| Syngene Intl. | 568.05 | 2.52 | 699.95 | 508.10 | 22803.23 |
| Ipca Labs. | 888.95 | -0.76 | 1383.55 | 831.40 | 22552.66 |
| Pfizer | 4102.30 | -0.25 | 6164.80 | 4068.85 | 18768.02 |
Quick Links for Parnax Lab:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
